FDA Inspection 1204268 — IDB Holland B.V.
The FDA completed an inspection of IDB Holland B.V. on Jan 12, 2022 in Baarle-Nassau. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baarle-Nassau (Netherlands)
Additional Details
Mutual Recognition Agreement (MRA)